Recruiting studies: Proteinuric Kidney Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · 161 location(s) · Boehringer Ingelheim · NCT07355296 Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinur
Phase 2 · 2 location(s) · Everest Medicines (China) Co.,Ltd. · NCT07614477 A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
Phase 2 · 79 location(s) · Maze Therapeutics · NCT06830629 Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Phase 2/Phase 3 · 318 location(s) · Vertex Pharmaceuticals Incorporated · NCT05312879 Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Phase 2 · 47 location(s) · Travere Therapeutics, Inc. · NCT05003986 Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001
Phase 1 · 19 location(s) · Everest Medicines (China) Co.,Ltd. · NCT05800873 A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide
Phase 3 · 1 location(s) · Sarfez Pharmaceuticals, Inc. · NCT07223502

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.